葡萄膜黑色素瘤眼球质子治疗后角膜基底神经丛变化的共聚焦显微镜评估
这项前瞻性队列研究对58例葡萄膜黑色素瘤患者行眼球质子治疗(OPT),用角膜共聚焦显微镜纵向评估角膜基底神经丛(SNP)。治疗后3个月和12个月角膜神经纤维密度、分支密度和长度均显著下降,12个月仅部分恢复;神经丢失与治疗体积和角膜照射量相关,而角膜敏感度和细胞密度未变,患者报告结局未一致反映结构去神经化。
要点
- OPT后3和12个月角膜神经纤维密度、分支密度及长度均显著下降。
- 神经丢失与临床靶体积等治疗相关暴露相关,12个月仅部分恢复。
- 角膜敏感度和细胞密度未变,OSDI和周边视野等患者报告结局变化不一致。
核心结论
- 眼球质子治疗与角膜基底神经丛参数显著降低相关,12个月时仅部分恢复。
- 神经丢失程度与更大的治疗体积和更多角膜照射相关。
- 细胞密度和角膜敏感度保持不变,患者报告结局未一致反映结构去神经化。
研究设计与样本
- 前瞻性临床队列研究,纳入58例葡萄膜黑色素瘤患者(58眼)。
- 54眼有可评估的基线角膜共聚焦显微镜图像,40例构成纵向分析队列。
- 随访数据:3个月时30例,12个月时27例。
主要发现
- 角膜神经纤维密度从18.2降至3个月11.4和12个月12.7 no./mm²(P=.002和.001)。
- 角膜神经分支密度从23.9降至3个月13.5和12个月15.8 no./mm²(P=.012和.040)。
- 角膜神经纤维长度从11.0降至3个月6.2和12个月7.3 mm/mm²(均P<.001)。
- 神经纤维迂曲度在3个月下降(P=.018),12个月接近基线(P=.28)。
- OSDI在12个月升高(P=.049),NEI VFQ-25中仅周边视野下降(84-68;P=.006)。
关键数值与推荐
- 主要结局为角膜神经纤维密度、分支密度和长度的变化。
- 次要结局包括神经纤维迂曲度、细胞密度、角膜敏感度、OSDI及部分NEI VFQ-25领域。
- Benjamini-Hochberg校正后,3个月神经纤维迂曲度、12个月OSDI和12个月细胞密度变化不再显著。
- 角膜敏感度无显著变化。
临床怎么用
- 对接受眼球质子治疗的葡萄膜黑色素瘤患者,可考虑用角膜共聚焦显微镜监测角膜神经结构变化。
- 治疗体积较大或角膜照射较多的患者可能神经丢失更明显,需关注角膜神经状态。
- 患者报告结局与结构去神经化不完全一致,临床评估需结合客观神经影像。
局限性
- 纵向分析队列样本量有限,随访至12个月时仅27例。
- 部分结局经多重校正后不再显著,需谨慎解读。
- 患者报告结局未一致反映结构去神经化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate longitudinal changes in the subbasal nerve plexus (SNP) after ocular proton therapy (OPT) in eyes with uveal melanoma and associated changes in corneal sensitivity, cell density, and patient-reported outcomes. DESIGN: Prospective clinical cohort study. SUBJECTS: Fifty-eight patients (58 eyes) with uveal melanoma were enrolled; 54 had evaluable baseline corneal confocal microscopy images, and 40 formed the longitudinal analysis cohort. Follow-up data were available for 30 patients at 3 months and 27 patients at 12 months. METHODS: Corneal confocal microscopy was used to assess SNP parameters and cell density. Corneal sensitivity was measured with a Cochet-Bonnet esthesiometer. Patient-reported outcomes were assessed using the German Ocular Surface Disease Index (OSDI) and selected domains from the German version of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). Examinations were performed before OPT and at 3 and 12 months after OPT. MAIN OUTCOME MEASURES: Primary outcome measures were changes in corneal nerve fiber density, corneal nerve branch density, and corneal nerve fiber length. Secondary outcome measures included corneal nerve fiber tortuosity (CNFT), cell density, corneal sensitivity, OSDI, and selected NEI VFQ-25 domains. RESULTS: Corneal nerve fiber density decreased from 18.2 to 11.4 (3 months) and 12.7 no./mm² (12 months) (P = .002 and .001). Corneal nerve branch density decreased from 23.9 to 13.5 and 15.8 no./mm² (P = .012 and .040), and corneal nerve fiber length from 11.0 to 6.2 and 7.3 mm/mm² (both P < .001). Nerve loss was associated with treatment-related exposure, particularly the clinical target volume. CNFT decreased at 3 months (P = .018) and approached baseline at 12 months (P = .28). Corneal sensitivity did not change significantly. OSDI increased at 12 months (P = .049). After Benjamini-Hochberg correction, the 3-month CNFT, 12-month OSDI, and 12-month cell density changes were no longer significant. Among NEI VFQ-25 domains, only peripheral vision declined (84-68; P = .006). CONCLUSIONS: OPT was associated with marked reduction of SNP parameters, with only partial recovery by 12 months. Greater nerve loss was associated with larger treatment volumes and greater corneal irradiation. Cell density and corneal sensitivity remained unchanged, whereas patient-reported outcomes did not consistently reflect structural denervation.
引用
- Knappe C, Prystupa C, Jami Z, et al. Subbasal Nerve Plexus Alterations Following Ocular Proton Therapy in Uveal Melanoma Assessed by Corneal Confocal Microscopy. Am J Ophthalmol. 2026. PMID: 42822587. doi:10.1016/j.ajo.2026.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。